Literature DB >> 3180587

Patellofemoral arthroplasty. A three- to nine-year follow-up study.

R A Arciero1, H E Toomey.   

Abstract

Twenty-two patients with 25 patellofemoral arthroplasties (resurfacing of the patella and femoral groove) were evaluated to assess long-term results. A past history of patellofemoral malalignment or instability was obtained from 14 patients. Preoperative roentgenograms demonstrated patellofemoral osteoarthritis in all 25 knees; five patients had both tibiofemoral and patellofemoral osteoarthritis. The average age at the time of surgery was 62 years and follow-up time averaged 5.3 years. Results were determined using a modified Hungerford knee rating scale. Follow-up roentgenograms were evaluated for mechanical failure and progressive deterioration of the tibiofemoral joint. Eighteen of 25 (72%) patellofemoral arthroplasties were rated excellent or good. However, 15 of 17 patellofemoral arthroplasties (88%), all performed on women, had satisfactory results. There were seven failures. The presence of tibiofemoral osteoarthritis adversely affected the outcome; excluding the five patients with tibiofemoral osteoarthritis, 17 of 20 patellofemoral arthroplasties (85%) had satisfactory results. Other reasons for failure were malposition of the components and persistent patellofemoral malalignment. Mechanical failure was not observed. Patellofemoral arthroplasty may be indicated for patients with osteoarthritis limited to the patellofemoral compartment.

Entities:  

Mesh:

Year:  1988        PMID: 3180587

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

Review 1.  Patellofemoral arthroplasty, where are we today?

Authors:  Sébastien Lustig; Robert A Magnussen; Diane L Dahm; David Parker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-03-10       Impact factor: 4.342

2.  Total knee arthroplasty without patellar resurfacing.

Authors:  In Suk Oh; Myung Ku Kim; Dong Seok You; Seok Bong Kang; Kwan Hee Lee
Journal:  Int Orthop       Date:  2006-05-06       Impact factor: 3.075

3.  Are revisions of patellofemoral arthroplasties more like primary or revision TKAs.

Authors:  Sébastien Parratte; Alexandre Lunebourg; Matthieu Ollivier; Matthew P Abdel; Jean-Noël A Argenson
Journal:  Clin Orthop Relat Res       Date:  2015-01       Impact factor: 4.176

Review 4.  Complications after patello-femoral versus total knee replacement in the treatment of isolated patello-femoral osteoarthritis. A meta-analysis.

Authors:  C J Dy; N Franco; Y Ma; M Mazumdar; M M McCarthy; A Gonzalez Della Valle
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-11       Impact factor: 4.342

5.  Short-term outcomes of robotically assisted patello-femoral arthroplasty.

Authors:  Ugur Turktas; Ahmet Piskin; Gary G Poehling
Journal:  Int Orthop       Date:  2015-05-05       Impact factor: 3.075

Review 6.  Advances in Patellofemoral Arthroplasty.

Authors:  Sabrina M Strickland; Mackenzie L Bird; Alexander B Christ
Journal:  Curr Rev Musculoskelet Med       Date:  2018-06

Review 7.  Isolated patellofemoral osteoarthritis.

Authors:  Hans-Peter W van Jonbergen; Rudolf W Poolman; Albert van Kampen
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

Review 8.  Survivorship and functional outcomes of patellofemoral arthroplasty: a systematic review.

Authors:  J P van der List; H Chawla; H A Zuiderbaan; A D Pearle
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-11-21       Impact factor: 4.342

9.  The Avon Patellofemoral Joint Replacement: Mid-Term Prospective Results from an Independent Centre.

Authors:  Pouya Akhbari; Tamer Malak; Sebastian Dawson-Bowling; Debra East; Kim Miles; P Adrian Butler-Manuel
Journal:  Clin Orthop Surg       Date:  2015-05-18

10.  Conversion of patellofemoral arthroplasty to total knee arthroplasty: A matched case-control study of 13 patients.

Authors:  Hans-Peter W van Jonbergen; Dirk M Werkman; Albert van Kampen
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.